Are you Dr. Butler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Medical Plaza
365
Los Angeles, CA 90095Phone+1 310-825-7922
Summary
- Dr. Peter Butler, MD is an endocrinologist in Los Angeles, California. He is currently licensed to practice medicine in California, Minnesota, and North Carolina. He is a Professor at UCLA School of Medicine.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1993
- Freeman Health System1982 - 1984
- Birmingham University Medical SchoolClass of 1980
Certifications & Licensure
- CA State Medical License 2000 - 2025
- MN State Medical License 1993 - 2002
- NC State Medical License 1990 - 1992
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 310 citationsIncreased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than ...Alexandra E. Butler, Juliette Janson, Walter C. Soeller, Peter C. Butler
Diabetes. 2003-09-01 - 93 citationsGlucagon like peptide-1 receptor expression in the human thyroid glandBelinda Gier, Peter C. Butler, Chi K. Lai, David Kirakossian, Matthew M. DeNicola
The Journal of Clinical Endocrinology and Metabolism. 2012-01-01 - 666 citationsIncreased Risk of Type 2 Diabetes in Alzheimer DiseaseJuliette Janson, Thomas Laedtke, Joseph E. Parisi, Peter C. O'Brien, Ronald C. Petersen
Diabetes. 2004-02-01
Press Mentions
- ® Announces Latest Institute for Value-Based Medicine® MeetingApril 2nd, 2019
- Type 2 Diabetes Drug May Cause CancerJanuary 29th, 2016
Grant Support
- Capacity And Mechanisms Of Beta Cell Regeneration In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2012
- Role Of IAPP In Islet Dysfunction In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2012
- Role Of Pulsatile Insulin SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Role Of Pulsatile Insulin Secretion.National Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- Role Of Pulsatile Insulin Secretion.National Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
- Role Of IAPP In Islet Dysfunction In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
- Restoration Of First Phase Insulin Secretion On Pulsatile Secretion In NIDDMNational Center For Research Resources1996–1997
- Pulsatile Insulin Secretion By Hepatic Transplanted IsletsNational Center For Research Resources1995
- Pulsatile Insulin Secretion On Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1995
- Role Of Pulsatile Insulin Secretion On Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
- Isotopes Of Glucose, Leucine, And Palmitate As Irreversible Tracers Of GlucoseNational Center For Research Resources1992